RxDoctor Payments Data

Sarkis Derderian

Pulmonary Disease · Columbia, SCNPI 1427036375

Payments from drug & device makers

$1,787in general payments, 2019–2025

Across 109 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$333
  • GSK$227
  • AstraZeneca$212
  • Insmed, Inc.$209
  • Sanofi$106
  • Regeneron Healthcare Solutions, Inc.$99
  • plus $603 from 13 others

What the payments were for

  • Food & beverage$1,68894%
  • Education$996%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,787 in reported general payments places this provider in the 40th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina

Other pulmonary disease in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →